BlackRock
GILD icon

BlackRock’s Gilead Sciences GILD Stock Holding History

BlackRock’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-900
Closed -$71K – 3766
2016
Q3 		$71K Buy
+900
New +$73.1K ﹤0.01% 2788

Other funds holding GILD

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock's GILD Position: Q2 2026 in Review

BlackRock increased its Gilead Sciences (GILD) stake by 2.4% in Q2 2026, buying an estimated $373M and bringing the position to 121,844,108 shares worth $15.4B. The position accounts for 0.23% of the portfolio, ranked #68.

BlackRock first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $16.6B in Q1 2026. 2,281 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • BlackRock held 121,844,108 shares of Gilead Sciences worth $15.4B as of Q2 2026.
  • BlackRock bought 2,833,135 Gilead Sciences shares in Q2 2026, an estimated $373M.
  • Gilead Sciences made up 0.23% of BlackRock's portfolio in Q2 2026, its #68 holding.
  • BlackRock first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • BlackRock's Gilead Sciences position peaked at $16.6B in Q1 2026.
  • 2,281 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.